[Skip to Navigation]
Views 573
Citations 0
Comment & Response
August 13, 2020

Targeted Intraoperative Radiotherapy for Early Breast Cancer

Author Affiliations
  • 1Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio
  • 2Alpert Medical School of Brown University, Lifespan Cancer Institute, Providence, Rhode Island
  • 321st Century Oncology, Farmington Hills, Michigan
JAMA Oncol. 2020;6(10):1635-1636. doi:10.1001/jamaoncol.2020.2713

To the Editor We read with interest the report on the long-term recurrence and survival outcomes after treatment with delayed second-procedure targeted intraoperative radiotherapy (IORT) vs whole-breast radiotherapy by Vaidya et al.1 Since the publication of 5-year outcomes from the TARGIT-A trial,2 the oncology community has awaited long-term outcomes from the study to evaluate the utility of IORT for early breast cancer. The recent publication of the delayed-treatment cohort of patients from the TARGIT-A trial has now provided additional information. The study found that 5-year local recurrence rates were 3.96% with delayed second-procedure IORT compared with 1.05% with whole-breast irradiation (WBI), which was not noninferior. No difference in mastectomy-free survival, distant disease-free survival, or overall survival was noted.1

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words